Peer review reports
From: HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3
Original Submission | ||
---|---|---|
18 Jun 2021 | Submitted | Original manuscript |
29 Jul 2021 | Reviewed | Reviewer Report |
31 Jul 2021 | Reviewed | Reviewer Report |
9 Nov 2021 | Author responded | Author comments - Jianrui Sun |
Resubmission - Version 2 | ||
9 Nov 2021 | Submitted | Manuscript version 2 |
17 Nov 2021 | Author responded | Author comments - Jianrui Sun |
Resubmission - Version 3 | ||
17 Nov 2021 | Submitted | Manuscript version 3 |
2 Dec 2021 | Author responded | Author comments - Jianrui Sun |
Resubmission - Version 4 | ||
2 Dec 2021 | Submitted | Manuscript version 4 |
16 Dec 2021 | Author responded | Author comments - Jianrui Sun |
Resubmission - Version 5 | ||
16 Dec 2021 | Submitted | Manuscript version 5 |
14 Jan 2022 | Reviewed | Reviewer Report |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
7 Feb 2022 | Editorially accepted | |
6 Apr 2022 | Article published | 10.1186/s12885-022-09462-y |